Table 1.
Baseline demographic and angiographic information stratified by gender
| Men (n=3502) |
Women (n=1416) |
P-Value | |
|---|---|---|---|
| Age (Years), mean ± SD | 60.8 ± 13.3 | 68.4 ± 14.1 | <0.001 |
| BMI, mean ± SD | 29.1 ± 5.6 | 28.6 ± 7.2 | 0.002 |
| Hypertension, (%) | 1939 (55.7) | 934 (66.7) | <0.001 |
| Dyslipidemia, (%) | 1922 (56.1) | 754 (54.8) | 0.44 |
| Diabetes, (%) | 607 (17.4) | 305 (21.7) | <0.001 |
| History of CAD, (%) | 1102 (31.5) | 390 (27.7) | 0.009 |
| History of Stroke, (%) | 108 (3.1) | 55 (3.9) | 0.15 |
| History of Smoking, (%) | 2276 (65.5) | 728 (52.0) | <0.001 |
| Current Smoker, (%) | 1293 (37.2) | 421 (30.1) | <0.001 |
| History of PCI, (%) | 801 (23.0) | 253 (18.0) | <0.001 |
| History of MI, (%) | 761 (21.9) | 252 (17.9) | 0.002 |
| History of CABG, (%) | 275 (7.9) | 69 (4.9) | <0.001 |
| Killip Class | |||
| 1, (%) | 3079 (88.0) | 1169 (82.6) | <0.001 |
| 2/4, (%) | 419 (12.0) | 247 (17.4) | |
| Cardiac Arrest Pre-PCI, (%) | 374 (10.7) | 128 (9.0) | 0.084 |
| Cardiogenic Shock Pre-PCI, (%) | 281 (8.0) | 162 (11.5) | <0.001 |
| Anterior MI, (%) | 1234 (35.8) | 496 (35.4) | 0.78 |
| Ejection Fraction (%), mean ± SD | 47.9 ± 13.2 | 47.7 ± 14.7 | 0.52 |
| Culprit Artery | |||
| Graft, (%) | 86 (2.5) | 21 (1.5) | <0.001 |
| Left Main, (%) | 32 (0.9) | 16 (1.1) | |
| LAD, (%) | 1109 (31.7) | 409 (28.9) | |
| LCx, (%) | 432 (12.4) | 154 (10.9) | |
| RCA, (%) | 1257 (35.9) | 492 (34.8) | |
| None/Unknown/Unclear, (%) | 583 (16.7) | 323 (22.8) | |
| Peak CK mg/dl, median(25th, 75th percentile) | 819 (284, 1807) | 538 (182, 1516) | <0.001 |
| Peak CKMB mg/dl, median(25th, 75th percentile) | 77 (21, 183) | 54 (16, 160) | <0.001 |
| TIMI Flow Pre PCI | |||
| 0/1, (%) | 1712 (51.8) | 602 (45.2) | <0.001 |
| 2/3, (%) | 1594 (48.2) | 729 (54.8) | |
| TIMI Flow Post PCI | |||
| 0/1, (%) | 73 (2.2) | 30 (2.3) | 0.93 |
| 2/3, (%) | 3233 (97.8) | 1302 (97.8) | |
| Pre-Revascularization Medication | |||
| Aspirin, (%) | 3474 (97.7) | 1361 (97.1) | 0.29 |
| Anti-thrombotic*, (%) | 3243 (95.3) | 1299 (95.4) | 0.86 |
| Thienopyridine, (%) | 1377 (93.9) | 566 (93.3) | 0.60 |
BMI = body mass index; CAD = coronary artery disease; PCI = percutaneous coronary intervention; MI = myocardial infarction; CABG = coronary artery bypass graft; LAD = left anterior descending; CK = creatine kinase; CKMB = creatine kinase MB
*
includes unfractionated heparin, low-molecular-weight heparin, or bivaluridin